Mellozzan (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors located in the suprachiasmatic nucleus of the hypothalamus. By binding these receptors, it mimics the natural nighttime rise in melatonin, signaling the body that it is time to sleep and thereby helping to synchronize the internal circadian rhythm with external light‑dark cues.

The appropriate dose of Mellozzan is determined by a qualified healthcare professional based on the individual’s age, the specific sleep condition being treated, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use in pregnancy and lactation are limited. Healthcare providers generally recommend caution and may advise against routine use unless the potential benefit outweighs any possible risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To request Mellozzan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and assistance with import documentation.

Unlike benzodiazepines or antihistamine sleep aids, melatonin works by restoring the body’s natural hormonal signal rather than depressing central nervous system activity. This generally results in fewer next‑day residual effects and a lower risk of dependence, although individual response can vary and some patients may still experience mild drowsiness.

Mellozzan should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat and direct sunlight, and keep out of reach of children. No refrigeration is required for this oral formulation.

Mellozzan is taken orally, usually with a glass of water. For best effect, it is commonly recommended to take the tablet 30‑60 minutes before the desired bedtime, following the dosing schedule prescribed by the treating clinician.

Although rare, serious adverse reactions can include severe allergic responses such as rash, swelling, or anaphylaxis, as well as worsening depression or rare seizure activity. Patients should seek immediate medical attention if they experience any signs of a severe reaction.

Mellozzan should be avoided by individuals with known hypersensitivity to melatonin or any excipients in the tablet. Caution is also advised for patients with uncontrolled epilepsy, severe depression, or those taking medications that may interact significantly, such as anticoagulants or potent CNS depressants. A healthcare professional should evaluate suitability before use.